The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia |
Children’s Hospital & Research Center at Oakland / Cheryl Peretz, MD |
Young Investigator Grants |
2019 |
California |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital / Charles Mullighan, MD |
Innovation Grants |
2019 |
Tennessee |
Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers |
Children’s Hospital of Philadelphia / Claudia Zapata, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas |
New York University School of Medicine / Danny Reinberg, PhD |
Reach Grants |
2019 |
New York |
Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth |
Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD |
Crazy 8 Pilots |
2019 |
Massachusetts |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2019 |
Massachusetts |